These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31561176)

  • 1. Complications and Survivorship Trends After Primary Debulking Surgery for Ovarian Cancer.
    Xu Z; Becerra AZ; Justiniano CF; Aquina CT; Fleming FJ; Boscoe FP; Schymura MJ; Sinno AK; Chaoul J; Morrow GR; Minasian L; Temkin SM
    J Surg Res; 2020 Feb; 246():34-41. PubMed ID: 31561176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
    Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis.
    Ghirardi V; Moruzzi MC; Bizzarri N; Vargiu V; D'Indinosante M; Garganese G; Pasciuto T; Loverro M; Scambia G; Fagotti A
    Gynecol Oncol; 2020 Apr; 157(1):209-213. PubMed ID: 31952843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.
    Kranawetter M; Ataseven B; Grimm C; Schneider S; Riss S; Alesina P; Prader S; Walz MK; Harpain F; Stift A; Heitz F; Reinthaller A; Polterauer S; Harter P; du Bois A
    Gynecol Oncol; 2019 Sep; 154(3):577-582. PubMed ID: 31235241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer.
    Narasimhulu DM; Kumar A; Weaver AL; McGree ME; Langstraat CL; Cliby WA
    Gynecol Oncol; 2019 Oct; 155(1):58-62. PubMed ID: 31402165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer.
    Hasselgren E; Hertzberg D; Camderman T; Björne H; Salehi S
    Gynecol Oncol; 2021 May; 161(2):402-407. PubMed ID: 33715894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events.
    Straubhar AM; Wolf JL; Zhou MQC; Iasonos A; Cham S; Wright JD; Long Roche K; Chi DS; Zivanovic O
    Gynecol Oncol; 2021 Feb; 160(2):438-444. PubMed ID: 33272645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Complications of Upfront Ovarian Cancer Surgery and Their Effects on Chemotherapy Delay.
    Heikkinen J; Kärkkäinen H; Eloranta ML; Anttila M
    Curr Oncol; 2024 Sep; 31(9):5630-5642. PubMed ID: 39330045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for septic adverse events and their impact on survival in advanced ovarian cancer patients treated with neoadjuvant chemotherapy and interval debulking surgery.
    Son JH; Lee JH; Jung JA; Kong TW; Paek J; Chang SJ; Ryu HS
    Gynecol Oncol; 2018 Oct; 151(1):32-38. PubMed ID: 30122310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative complications in women with ovarian cancer stratified by cytoreductive surgery outcome.
    Polan RM; Slota JM; Barber EL
    J Surg Oncol; 2023 Oct; 128(5):891-901. PubMed ID: 37382209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
    Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
    J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survival.
    Ross MS; Burriss ME; Winger DG; Edwards RP; Courtney-Brooks M; Boisen MM
    Gynecol Oncol; 2018 Aug; 150(2):306-310. PubMed ID: 29929924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer.
    Di Donato V; Di Pinto A; Giannini A; Caruso G; D'Oria O; Tomao F; Fischetti M; Perniola G; Palaia I; Muzii L; Benedetti Panici P
    Gynecol Oncol; 2021 Apr; 161(1):4-10. PubMed ID: 33223220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technical essentials and safety analysis of "rolling carpet" cytoreduction surgery in stage Ⅲc epithelial ovarian cancer].
    Liu H; Shi Y; Zhang GN; Yu J; Xu SQ; Wang DF; Fan Y; Song SQ; Zhou FZ
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):521-528. PubMed ID: 32854476
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary debulking surgery vs. interval debulking surgery for advanced ovarian cancer: review of the literature and meta-analysis.
    Chiofalo B; Bruni S; Certelli C; Sperduti I; Baiocco E; Vizza E
    Minerva Med; 2019 Aug; 110(4):330-340. PubMed ID: 31081304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
    Manning-Geist BL; Alimena S; Del Carmen MG; Goodman A; Clark RM; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Gynecol Oncol; 2019 Apr; 153(1):63-67. PubMed ID: 30635213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of surgery in advanced ovarian cancer varies between geographical regions; opportunities for improvement in The Netherlands.
    Timmermans M; Sonke GS; Slangen BFM; Baalbergen A; Bekkers RLM; Fons G; Gerestein CG; Kruse AJ; Roes EM; Zusterzeel PLM; Van de Vijver KK; Kruitwagen RFPM; van der Aa MA
    Eur J Surg Oncol; 2019 Aug; 45(8):1425-1431. PubMed ID: 31027945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
    Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
    Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.